FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q1 2022

SEC EDGAR SourceSEC Filings

Top Holdings321 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
SPYSPY
PUT

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

5.7M$2.6B12.4%
Increased

THERMO FISHER SCIENTIFIC INC

1.2M$722.9M3.5%$393.93+49.49%
10 qtrssince 2019-Q4
Increased
72

IQVIA HOLDINGS INC

3.1M$720.8M3.5%$143.62+61.06%
14 qtrssince 2018-Q4
Increased
62

BOSTON SCIENTIFIC CORP

15.7M$697.1M3.4%$38.48+16.17%
7 qtrssince 2020-Q3
Decreased
0

TRANSUNION

6.2M$639.5M3.1%$95.39+6.60%
14 qtrssince 2018-Q4
Increased
93

ARAMARK

16.5M$619.6M3.0%$24.89+5.20%
6 qtrssince 2020-Q4
Decreased
0

HOWMET AEROSPACE INC

13.6M$489.7M2.4%$28.75+23.38%
8 qtrssince 2020-Q2
Decreased
0

WABTEC CORP

4.9M$472M2.3%$67.00+44.79%
14 qtrssince 2018-Q4
Decreased
0

ALPHABET INC-CL C

167,807$468.7M2.3%$83.58+69.39%
14 qtrssince 2018-Q4
Decreased
0

META PLATFORMS INC-CLASS A

2.1M$459.1M2.2%$226.17+0.04%
14 qtrssince 2018-Q4
Increased
75
ZNGAZNGADelisted

ZYNGA INC

44.5M$410.9M2.0%
1 qtr
New
71

MICROSOFT CORP

1.3M$396.5M1.9%$136.50+122.94%
14 qtrssince 2018-Q4
Decreased
0

MASTERCARD INC - A

1.1M$384.8M1.9%$348.64+1.48%
5 qtrssince 2021-Q1
Decreased
0

ANTHEM INC

768,775$377.6M1.8%$279.05+70.78%
14 qtrssince 2018-Q4
Increased
50

SALESFORCE.COM INC

1.8M$373.3M1.8%$202.72+4.76%
10 qtrssince 2019-Q4
Increased
70

BLACKSTONE INC

2.9M$371.1M1.8%$57.25+89.70%
9 qtrssince 2020-Q1
Increased
59

CENTENE CORP

4.1M$341.2M1.6%$57.70+49.68%
9 qtrssince 2020-Q1
Decreased
0

NEW YORK TIMES CO-A

7.3M$336.4M1.6%$42.26+5.87%
8 qtrssince 2020-Q2
Decreased
0

RAYTHEON TECHNOLOGIES CORP

3.4M$335.4M1.6%$65.86+238.53%
6 qtrssince 2020-Q4
Decreased
0

AON PLC

1M$330.2M1.6%$193.94+62.92%
8 qtrssince 2020-Q2
Decreased
0
$20.7B
AUM
321
Positions
Q1 2022
Filing
Rating · 1.5
Quarterly Portfolio Change
+15%Q4'20$16.6B+21%Q1'21$20.1B+22%Q2'21$24.5B-13%Q3'21$21.4B-7%Q4'21$20B+3%Q1'22$20.7B
Activity profile
$ moved · Q1'22
New27%Increased30%Decreased15%Exited28%
Composition
Equity vs derivatives
Equity87%Puts13%Calls0%
Holding period
Avg 3.7 quarters
<1Q18%1-4Q53%1-2Y14%2Y+15%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $20.7B across 321 positions as of Q1 2022. Top holdings: SPY (12.4%), TMO (3.5%), IQV (3.5%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 1.5/5.0.

Q1 2022 Summary

Active quarter - 58 new positions, 37 exits, 45 increased. Top move: TRU (INCREASED, conviction 93). Portfolio: $20.7B across 321 positions.

Top holdings by portfolio weight

Total AUM$18B
TMO3.49%
IQV3.48%
BSX3.36%
TRU3.09%
ARMK2.99%
HWM2.36%
WAB2.28%
GOOG2.26%
META2.22%
ZNGA1.98%
Other1.91%

Portfolio allocation by GICS sector

Sectors11
Healthcare30.95%
Unknown17.82%
Technology14.67%
Industrials13.28%
Financial Services12.53%
Communication Services7.52%
Basic Materials1.78%
Real Estate0.67%
Utilities0.44%
Energy0.28%
Other0.06%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown, Technology
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track Record60
Conviction43
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q3 2024 Q2 2026+8.5M shares+$314.1M
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 Q2 2026+9M shares+$755.7M
5Q
BSXBSXBOSTON SCIENTIFIC CORP
Q2 2025 Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used